Procoagulant Activity of Purified Protein Derivative-Stimulated Pleural Effusion Mononuclear Cells in Tuberculous Pleurisy

Respiration

Volumn 64, Issue 2, 1997, Pages 152-158

  Hoheisel, Gerhard ^a   Roth, Michael ^b   Chan, Christopher H S ^c   Tsakiris, Dimitrios A ^b   Fehr, Balthasar ^b   Ruff, Paul W ^b   Perruchoud, André P ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Heart failure; Lung cancer; Mononuclear cells; Pleural effusion; Procoagulant activity; Purified protein derivative; Tuberculosis

Indexed keywords

PROCOAGULANT; THROMBOPLASTIN; TUBERCULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LUNG CANCER; LUNG DISEASE; MALE; MONONUCLEAR CELL; PLEURA EFFUSION; PRIORITY JOURNAL; TIME; TUBERCULOUS PLEURISY;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; CELL COUNT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; THROMBOPLASTIN; TUBERCULIN; TUBERCULOSIS, PLEURAL;

EID: 0031057459     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000196660     Document Type: Article

References (26)

1. Gralnick HR: Cancer cell procoagulant activity; in Donati MB, Davidson JF, Garattini S (eds): Malignancy and the Hemostatic System, New York, Raven Press, 1981, pp 57-78.
2. Nakstad B, Lybcrg T, Skonsberg OH, Boye NP: Local activation of the coagulation and fibrinolysis systems in lung disease, Thromb Res 1990:57:827-838.
3. Moerloose PD, Benedetti ED, Nicod L, Vifian C, Reber G: Procoagulant activity in bron-choalveolar fluids: No relationship with tissue factor pathway inhibitor activity, Thromb Res 1992:65:507-518.
4. Idell S, Gonzalez K, Bradford H, Macarthur CK, Fein AM, Maunder RJ, Garcia JGN, Griffith DE, Weiland J, Martin TR, McLarthv J, Fair DS, Walsh PN, Colman RW: Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome, Am Rev RespirDis 1987:136:1466-1474.
5. Seeger W, Hübel J, Klapettek K, Pison U, Obertacke U, Joka T, Roka L: Procoagulant activity in bronchoalveolar lavage of severely traumatized patients- Relation to the development of acute respiratory distress, Thromb Res 1991:61:53-64.
6. Idell S, Girard W, Koenig KB, McLarty J, Fair DS: Abnormalities of pathways of fibrin turnover in the human pleural space, Am Rev Respir Dis 1991;144:187-194.
7. Stem D, Nawroth P, Handley D, Kisiel W: An endothelial cell-dcpcndent pathway of coagulation, Proc Natl Acad Sci USA 1985:82:2523-2527.
8. Barrowcliffe TW, Marshall DE, Trickett LP, Hubbard AR, Gray E, Thorpe R: Procoagulant activity of T lymphoblastoid cells in extrinsic and intrinsic coagulation systems, Thromb Haemost 1989;62:880-884.
9. Chapman HA, Stahl M, Allen CL, Yee R, Fair DS: Regulation of the procoagulant activity within the bronchoalveolar compartment of normal human lung, Am Rev Respir Dis 1988: 137:1417-1425.
10. Geczy CL, Meyer PA: Leukocyte procoagulant activity in man: An in vitro correlate of de-layed-type hypersensitivity, J Immunol 1982: 128:331-336.
11. Fujiwara H, Okuda Y, Fukukawa T, Tsuyugu-chi I: In vitro tuberculin reactivity of lymphocytes from patients with tuberculous pleurisy, Infect Immun 1982;35:402-409.
12. Ribera E, Espanol T, Martinez-Vazqucz JM, Ocana L, Encabo G: Lymphocyte proliferation and gamma-interfcron production after in vi-tro-stimulation with PPD, Chest 1990:97: 1381-1385.
13. Rickies RR, Hardin JA, Pitlick FA, Hover LW, Conrad ME: Tissue factor activity in lymphocyte cultures from normal individuals and patients with hemophilia A, J Clin Invest 1973: 52:1427-1434.
14. Chapman HA, Allen CL, Lee Stone O: Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease, Am Rev Respir Dis 1986:133:437-443.
15. Moison T, Chandrasekhar AJ, Robinson J, McKenna J, Marti G: Distribution of lymphocyte subpopulations in patients with exudative pleural effusions, Am Rev Respir Dis 1978; 117:507-511.
16. Barnes PF, Mistry SD, Cooper CL, Pirmez C, Rca TH, Modlin R: Compartmcntalizationofa CD4* lymphocyte subpopulation in tuberculous pleuritis, J Immunol 1989:142:1114-1119.
17. Fujiwara H, Tsuyuguchi I: Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculous pleurisy, Chest 1986;89:530-532.
18. Rossi G A, Balbi B, Manca F: Tuberculous pleural effusions, Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection, Am Rev RespirDis 1987:136:575-579.
19. Lorgat F, Keraan MM, Lukey PT, Ress SR: Evidence for in vitro generation of cytotoxic T cells, Am Rev RespirDis 1992;145:418-423.
20. Kotani J, Sato A, Havakawa H, Urano T, Takada Y, Takada A: Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis, Thromb Res 1995;77:493-504.
21. Hoheisel G, Roth M, Chan CHS, Ruff PW, Tsakiris DA, Hornung M, Perruchoud AP: Procoagulant activity of PPD-stimulated human lymphocytes after cryopreservation, Tuber Lung Dis 1994;75:441-446.
22. Lucivero G, Picrucci G, Bonomo L: Lymphocyte subsets in peripheral blood and pleural fluid, Eur Respir J 1988:1:337-340.
23. Albera C, Mabritto I, Ghio P, Scagliotti GV, Pozzi E: Lymphocyte subpopulations analysis in pleural and peripheral blood in patients w ith lymphocytic pleural effusions, Respiration 1991;58:65-71.
24. Guzman J, Bross KJ, Württemberger G, Freu-denberg N, Costabel U: Tuberculous pleural effusions: Lymphocyte phenotypes in comparison with other lymphocyte-rich effusions, Diagn Cytopathol 1989;5:139-144.
25. Geczy CL, Ryan J, Walsh J, Goldstein D: Lyni-phokine-induced monocvt procoagulant activity is depressed in patients with advanced malignancies, Int J Cancer 1986:37:677-681.
26. Edwards RL, Rickies FR, Cronlund M: Abnormalities of blood coagulation in patients with cancer, Mononuclear cell tissue factor generation, J Lab Clin Med 1981;96:917-928.